Top 3 Pitfalls of SAP S/4HANA Transformations in Life Sciences (and How to Avoid Them)

SAP S/4HANA projects fail due to predictable issues. Think about data, scope, integration, and governance. All the usual suspects. But Life Sciences adds regulatory complexity on top. Another layer that makes digital transformation not so simple to implement. The pitfalls of S/4HANA projects are actually not just predictable but also preventable. The question is: how?

With decades of experience in Life Sciences, and the SAP know-how that has brought S/4HANA transformation for multiple clients, we know the challenges that many in our sector face and how to prevent failure. In this blog, we cover the pitfalls that we have faced in the field and how we have course corrected to ensure success.

1. Stringent regulatory compliance and validation  

What’s the most common issue? 

One of the biggest mistakes in S/4HANA implementations is treating validation as a downstream activity rather than a design principle. Leaving validation until the final stage seems nonsensical, but it can easily happen when project teams focus so heavily on process design, system build, data migration, testing, and go-live readiness. They end up postponing until the later stages. This has numerous consequences due to critical design decisions having been implemented before validation requirements have taken place.

How does Life Sciences complexity factor in?

The complexity of the Life Sciences industry also makes this pitfall harder to avoid. How?  Because regulated Life Sciences processes are deeply embedded within ERP. Any system design decision can affect GxP compliance and data integrity. This raises the stakes significantly.

Also, validation expectations have evolved, with traditional Computer System Validation (CSV) approaches often relying on heavy documentation and extensive testing. But regulators are increasingly encouraging Computer Software Assurance (CSA), which focuses on critical thinking, risk prioritization and evidence-driven testing. Organizations that fail to modernize their validation approach often create unnecessary project overhead.

Plus, audit readiness is non-negotiable in Life Sciences. Regulatory inspections do not pause because an ERP transformation is underway. Life Sciences organizations must maintain complete traceability, change control records, validation evidence, and risk assessments throughout the entire transformation lifecycle. Without this, audit exposure increases significantly.

What are the consequences? 

As highlighted above, one of the principal consequences of treating validation as a downstream activity is project delays. Why? Because late identification of compliance gaps often creates bottlenecks during testing and go-live preparation, whilst validation dependencies can delay deployment significantly.

Then there’s costly rework. If compliance requirements are not embedded into initial design, teams have to reconfigure workflows, redesign approval processes, retest critical functionality, and rewrite documentation. All of which increases both cost and complexity.

Increased audit and compliance risk is another consequence. Incomplete validation documentation or weak controls can create regulatory findings after go-live. This risk extends beyond IT into product quality and patient safety.

How can you avoid pitfall #1?

The best approach that Life Sciences organizations can take is to embed “validation by design” into the transformation from day one. This is done by:

• Aligning IT, QA, and business stakeholders early
• Defining compliance requirements alongside functional requirements
• Applying risk-based validation strategies to prioritize critical GxP processes
• Maintaining continuous audit readiness throughout the program lifecycle

In Life Sciences, compliance cannot be layered onto an ERP implementation after the fact. It must shape and be the solid foundation of the transformation itself, right from the very start of the project. 

2. Complex data migration and integration  

What’s the most common issue?

Data is at the heart of every successful SAP S/4HANA program. Yet many Life Sciences organizations significantly underestimate the complexity involved in migrating and integrating enterprise data during transformation initiatives.

One of the most common mistakes is assuming data migration is primarily a technical exercise that can be addressed later in the project lifecycle. The reality is that data migration requires extensive business alignment, governance, cleansing, and harmonization long before go-live preparation begins.

How does Life Sciences complexity factor in?

For many Life Sciences organizations, legacy ERP environments have evolved over years (or even decades) through acquisitions, regional expansions, and changing regulatory requirements. As a result, critical business data is often fragmented across multiple systems, business units, and functions.

The challenge becomes even more complex in regulated environments where master data plays a direct role in compliance and operational continuity. Highly regulated data objects such as materials, products, batches, suppliers, quality specifications, serialization and traceability data, must remain accurate as well as standardized, and fully traceable throughout the transformation process.

At the same time, S/4HANA environments in Life Sciences rarely operate in isolation. They must integrate seamlessly with a broad ecosystem of systems supporting R&D, manufacturing, laboratory operations, quality management, and more.

What are the consequences?

Without a well-defined integration strategy, organizations risk recreating disconnected processes and data silos inside a modern ERP landscape. The consequences can be significant. In fact, poor quality or inconsistent data can lead to:

• Data integrity issues impacting compliance and reporting
• Operational disruptions during manufacturing or product release
• Reduced trust in the new ERP environment
• Increased manual workarounds post go-live

Similarly, weak integration planning often results in fragmented system landscapes built around temporary point-to-point connections that become increasingly difficult to maintain and scale over time.

How can you avoid pitfall #2?

Take a far more strategic approach to data and integration from the outset. One that begins with establishing a strong data governance framework early in the transformation program. Clear ownership, standardized definitions, and governance processes help ensure consistency across business functions and regions.

In parallel, organizations should invest in a robust master data management strategy that focuses not only on migration, but also on long-term data quality and operational governance. Integration architecture is equally critical. Rather than building short-term fixes or isolated interfaces, organizations should design scalable integration models that support future growth, evolving business requirements, and additional connected systems over time.

Ultimately, Life Sciences organizations that treat data as a strategic transformation asset (and not simply a technical deliverable) are far better positioned to realize the long-term value of S/4HANA.

3. Skill shortages (SAP + industry knowledge)

What’s the most common issue?

Over-reliance on SAP consultants who lack Life Sciences context. This is one of the big sins for S/4HANA transformations in Life Sciences. Teams built from SAP know-how and technical perspective struggle to fully understand the operational, quality, and compliance implications behind critical business processes in Life Science.

How does Life Sciences complexity factor in?

In Life Sciences, ERP transformation decisions cannot be made based on technology requirements alone. Teams must understand how system design affects:

• GxP compliance
• Validation requirements
• Product traceability
• Batch management
• Quality processes
• Manufacturing and supply chain operations

This creates a unique challenge for transformation programs. Life Sciences organizations do not simply need SAP experts. They need professionals who can bridge technology, regulatory expectations, and pharmaceutical operating models. Otherwise, any S/4HANA transformation is bound to fail when expertise is not the driving force.

What are the consequences?

Without the right expertise at the steering wheel, projects often encounter issues during later stages of delivery. For example, processes that appear technically sound during design workshops may later prove difficult to validate, operationally impractical, or misaligned with compliance requirements once testing begins. As a result, Life Sciences organizations can frequently experience:

• Poor design decisions that fail operational or compliance needs
• Significant rework during testing and validation phases
• Delays caused by redesign and retesting
• Misalignment between business, IT, and Quality teams
• Increased project costs and resource strain

This challenge is often compounded by internal resource limitations. Subject matter experts within manufacturing, quality, or supply chain functions are typically already managing demanding operational responsibilities, making it difficult for them to dedicate sufficient time to transformation activities.

How can you avoid pitfall #3?

To ensure a successful S/4HANA implementation, organizations need to proactively build blended teams that combine:

• SAP technical expertise
• Life Sciences domain knowledge
• Regulatory and validation experience
• Business process leadership

Partner selection also plays a critical role. Life Sciences organizations benefit significantly from working with teams that understand both S/4HANA capabilities and the realities of operating within regulated pharmaceutical environments.

Equally important is knowledge transfer throughout the program lifecycle. Transformation success should not depend entirely on external consultants. Internal teams need to develop the skills and understanding required to support, govern, and evolve the system long after go-live.

In complex Life Sciences transformations, experience is not just valuable. It is essential. Some would say it makes the difference between a controlled transformation and a costly recovery effort.

Case study: SAP S/4HANA implementation at a large pharma company

Let’s take a look at one of our most recent use cases: one of the world’s leading specialty pharmaceutical companies that has products being sold in over 50 countries, and a revenue of over $2.5 bn.

What was the challenge?

The pharmaceutical company was trying to increase its global footprint, including in acquisitions. They were in need of a global process and ERP solution to support their globalization and growth strategy, while also fully realizing their business case.

The client was struggling to advance to the next phase of the project mainly due to:

• Lack of regulatory compliance and validation knowledge
• Lack of resources (consultants) who have strong industry knowledge
• Project scope expansion with a lack of project governance and discipline
• Complex landscape with many satellite systems’ integration points with SAP

What was the scope of the project?

Tenthpin began the engagement by conducting a rapid assessment of the client’s existing project landscape and transformation challenges. Based on this assessment, we provided strategic guidance on how to stabilize and move the program forward successfully.

Rather than operating within a traditional two-layer structure of separate advisors and system integrators, Tenthpin acted as both a strategic business advisor and implementation partner. This streamlined governance, accelerated decision-making, and improved alignment between business and technical teams.

As a starting point, we introduced a pharmaceutical industry template built on established best practices. This provided the client with a proven baseline for processes, governance, and system design, alongside a clear and structured project roadmap. Strong governance was maintained throughout the program to protect the integrity of the template and minimize unnecessary customization.

Adopting industry best practices also required organizational change. The program encouraged greater ownership from business stakeholders, particularly key users and process owners, who became actively involved in design and decision-making activities rather than relying heavily on external consultants. This shift in engagement was critical in overcoming many of the challenges the project had faced previously.

In parallel, Tenthpin provided continuous guidance on how to execute the transformation within a regulated Life Sciences environment. Validation and compliance considerations were embedded throughout the project lifecycle to help ensure that both system design and business processes aligned with GxP requirements.

Finally, Tenthpin designed a scalable and future-ready architecture capable of supporting long-term growth and the seamless integration of multiple satellite systems. Experienced technical consultants supported the program end-to-end, helping ensure stability, integration consistency, and sustainable long-term operations.

What was the overall outcome?

First of all, the project had a successful go-live within the estimated timeline compared to the client’s initial struggle and delay before Tenthpin arrived. Because of standardized architecture design and discipline in adhering to our template process, post go-live support and transition was smooth and without disruption.

As a result, the Life Sciences organization transitioned from fragmented, region-specific processes to a standardized, data-driven operating model across entities. The client was able to ensure period-end closing, consolidation, and time for reporting; ultimately reducing delays and errors. A refined product costing methodology also ensured ongoing efficiency and continuous improvement.

Finally, we minimized point-to-point integrations, replacing them with centralized and standardized interfaces. By reducing the number of system interfaces by 30–40%, we substantially lowered maintenance effort and integration risk

Conclusion

Pitfalls exist in S/4HANA implementations across Life Sciences. While this blog only touches on three, they are the most prominent ones that we’ve seen Life Sciences companies navigate. The challenges of compliance, data migration, and skills shortage can be overcome when the right strategies are implemented from the beginning. That’s the same with all pitfalls that we haven’t touched upon. Planning, strategy; it’s the difference between success and failure.

But overcoming pitfalls in S/4HANA transformations are only the beginning of this multi-layered subject. Our next blog  will cover how to de-risk S/4HANA in Life Sciences. Be sure to keep an eye out for it.